Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
Farmers Insurance
Chubb
Teva
Harvard Business School
Cipla
Accenture
Boehringer Ingelheim
Mallinckrodt

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202637

« Back to Dashboard
NDA 202637 describes LANSOPRAZOLE, which is a drug marketed by Labs Liconsa, Natco Pharma Ltd, Sun Pharm Inds Ltd, Krka Tovarna Zdravil, Perrigo R And D, Dexcel Pharma, Wockhardt Ltd, Ani Pharms Inc, Sandoz, Teva Pharms, Ajanta Pharma Ltd, Mylan Pharms Inc, Zydus Hlthcare, Dr Reddys Labs Ltd, Wockhardt Usa, Rising Pharms Inc, Teva Pharms Usa, and Sandoz Inc, and is included in twenty-two NDAs. It is available from eighty-two suppliers. Additional details are available on the LANSOPRAZOLE profile page.

The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.

Summary for NDA: 202637

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202637

Mechanism of ActionProton Pump Inhibitors
Physiological EffectInhibition Gastric Acid Secretion

Suppliers and Packaging for NDA: 202637

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LANSOPRAZOLE
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL 202637 ANDA Sun Pharma Global FZE 47335-923 47335-923-18 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-923-18)
LANSOPRAZOLE
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL 202637 ANDA Sun Pharma Global FZE 47335-923 47335-923-61 10 BLISTER PACK in 1 BOX, UNIT-DOSE (47335-923-61) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength15MG
Approval Date:Sep 13, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
AstraZeneca
US Army
Chinese Patent Office
Queensland Health
Cerilliant
Novartis
McKesson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot